Learn more

BIOFOCUS DISCOVERY LTD

Overview
  • Total Patents
    50
About

BIOFOCUS DISCOVERY LTD has a total of 50 patent applications. Its first patent ever was published in 1993. It filed its patents most often in United Kingdom, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are CURACYTE DISCOVERY GMBH, PHARMAHUNGARY 2000 KFT and FUJIMOTO SEIYAKU KK.

Patent filings per year

Chart showing BIOFOCUS DISCOVERY LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Chadwick Mark P 10
#2 Russell Stephen J 8
#3 Birault Veronique 8
#4 Russell Stephen James 7
#5 Harris John C 3
#6 Morling Frances Joanne 3
#7 Chadwick Mark Philip 3
#8 Crossley Roger 3
#9 Kling Marcel 2
#10 Harris C John 2

Latest patents

Publication Filing date Title
GB0510880D0 Compound library
GB0508380D0 Ion channel focused compound library
GB0504979D0 Compound libraries
WO2005085252A1 Imidazo ‘1,2-a’ pyrazine compounds which interact with protein kinases
GB0504515D0 Compound library
GB0504066D0 Compounds which interact with the g-protein coupled receptor family
GB0500226D0 Compounds which bind to the active site of protein kinase enzymes
GB0426259D0 Compounds which interact with protein kinases
GB0425030D0 Kinase focussed compound library
GB0425026D0 Compounds which bind to the active site of protein kinase enzymes
GB0424054D0 Ion channel focused compound library
GB0416808D0 Ion channel focused compound library
WO2005003101A2 Pyrazine and pyridine derivatives as rho kinase inhibitors
GB0412962D0 Compound libraries
GB0409080D0 Compounds which interact with protein kinases
GB0404889D0 Compounds which interact with protein kinases
GB0403578D0 Compounds which interact with the G-protein coupled receptor family
GB0307214D0 Compounds capable of binding to the active site of protein kinases
AU2002319858A1 Methods for identifying receptor up- and downmodulators
US6528252B2 Methods for identifying a protease inhibitor